Antibiotics are the commonest cause of life-threatening immune-mediated drug reactions
that are considered off-target, including anaphylaxis, and organ-specific and severe …

The present guideline summarizes all aspects of patch testing for the diagnosis of contact
allergy in patients suspected of suffering, or having been suffering, from allergic contact …

Resolving conflict of interest The Joint Task Force on Practice Parameters (JTFPP) is
committed to ensuring that all guidelines are based on the best scientific evidence at the …

Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Following the emergency use authorization of the mRNA‐1273 vaccine on the 18th of
December 2020, two mRNA vaccines are in current use for the prevention of coronavirus …

When drug reactions resembling allergy occur, they are called drug hypersensitivity
reactions (DHR s) before showing the evidence of either drug‐specific antibodies or T cells …

Modern health care requires a proactive and individualized response to diseases,
combining precision diagnosis and personalized treatment. Accordingly, the approach to …

A recent survey of the European Academy of Allergy and Clinical Immunology (EAACI) Drug
Allergy Interest Group (DAIG) on how European allergy specialists deal with beta‐lactam …

The basophil activation test (BAT) has become a pervasive test for allergic response through
the development of flow cytometry, discovery of activation markers such as CD 63 and …

Drug hypersensitivity reactions (DHR s) are a matter of great concern, both for outpatient
and in hospital care. The evaluation of these patients is complex, because in vivo tests have …